Plasmacytomagenesis in E -v-abl transgenic mice is accelerated when apoptosis is restrained

Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy

(2014) Jens G. Lohr et al.   CANCER CELL

Mcl-1 is essential for the survival of plasma cells

(2013) Victor Peperzak et al.   NATURE IMMUNOLOGY

Enhanced stability of Mcl1, a prosurvival Bcl2 relative, blunts stress-induced apoptosis, causes male sterility, and promotes tumorigenesis

(2013) T. Okamoto et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis

(2012) Sandrine Sander et al.   CANCER CELL

MYC on the Path to Cancer

(2012) Chi V. Dang   CELL

Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis

(2012) M W Gramling et al.   CELL DEATH AND DIFFERENTIATION

Molecular pathogenesis of multiple myeloma and its premalignant precursor

(2012) W. Michael Kuehl et al.   JOURNAL OF CLINICAL INVESTIGATION

Reviewing once more the c-myc and Ras collaboration

(2011) Chenguang Wang et al.   CELL CYCLE

Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases

(2011) Andreas Strasser et al.   EMBO JOURNAL

Regulation of gene transcription by the oncoprotein MYC

(2011) Bernhard Lüscher et al.   GENE

Many Multiple Myelomas: Making More of the Molecular Mayhem

(2011) M. Chesi et al.   Hematology-American Society of Hematology Education Program

Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance

(2010) K. J. Campbell et al.   BLOOD

Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways

(2008) P. Lunghi et al.   BLOOD

AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center Malignancies

(2008) Marta Chesi et al.   CANCER CELL